Elite Medical Scribes Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Elite Medical Scribes's estimated annual revenue is currently $150.5M per year.(i)
  • Elite Medical Scribes's estimated revenue per employee is $337,500

Employee Data

  • Elite Medical Scribes has 446 Employees.(i)

Elite Medical Scribes's People

NameTitleEmail/Phone
1
Chief ScribeReveal Email/Phone
2
Implementation SpecialistReveal Email/Phone
3
Medical ScribeReveal Email/Phone
4
Medical ScribeReveal Email/Phone
5
Medical ScribeReveal Email/Phone
6
Medical ScribeReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3326M87990%N/AN/A
#2
$393.5M10414%N/AN/A
#3
$172.5M5115%N/AN/A
#4
$48.4M1637%N/AN/A
Add Company

What Is Elite Medical Scribes?

Elite Medical Scribes is the preeminent scribe training, staffing, and management company for leading healthcare systems, physician groups and clinics across the nation. With established methods and techniques refined through countless hours of clinical experience, Elite has developed a proprietary, best-in-class program, designed to maximize efficiency of patient care and enhance the overall quality of healthcare. Elite Medical Scribes was founded in 2008 with the goal of improving the quality of patient care and delivering uncompromised service to clinicians. Founders Yuriy Vasylenko, MBA, Marcin J. Kubiak, MBA, and Cody W. Wendlandt, MD developed the company concept based on their combined healthcare and business backgrounds.

keywords:N/A

N/A

Total Funding

446

Number of Employees

$150.5M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Elite Medical Scribes News

2022-03-22 - University of Arizona Stars Write Letter to NCAA on Lia ...

Gender is on the level of DNA and we do not have the medical ability ... Your scribes sound like they originate in some dark universe devoid...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M4465%N/A
#2
$91.1M45313%N/A
#3
$102.2M4542%N/A
#4
$82.7M4560%N/A
#5
$83.6M461N/AN/A